Listen to the Onco’Zine Brief hosted by Peter Holfland: A Commitment to Innovation in Medicines, Medical Devices and Healthcare TechnologiesContinue reading
Author Archive: AZBio
UA Health Sciences Researchers Seek to Treat Pain Caused by Chemotherapy Without Opioids
UA Health Sciences Start-up company Regulonix Receives Grant as Part of NIH “Helping to End Addiction Long-Term Initiative” (NIH Heal Initiative).Continue reading
Calling on Congress to Repeal The Medical Device Excise Tax
On September 24, 2019, a letter was sent to Congressional Leaders in the Senate and House leadership on behalf of a group of over six hundred innovators, patient groups, physicians, hospitals, venture capitalists and other stakeholders representing millions of patients and hundreds of thousands medical technology jobs, requesting that Congress prioritize repeal of the medical device excise tax before it causes any more harm to the innovation ecosystem. Continue reading
Marti Lindsey, PhD, of the University of Arizona, to be honored as the Michael A. Cusanovich Arizona Bioscience Educator of the Year
CHANDLER, Ariz. — (BUSINESS WIRE) — The Arizona Bioindustry Association (AZBio) today announced that Marti Lindsey, PhD, community engagement director for the Southwest Environmental Health Sciences Center at the University of Arizona College of Pharmacy and the founder and co-director of the KEYS High School Student Internship program at the UA BIO5 Institute, will be honored as the Michael A. Cusanovich Arizona Bioscience Educator of the Year at the AZBio Awards on Oct. 2, 2019.
“Learning opportunities are all around us,” stated Joan Koerber-Walker, president and CEO of AZBio. “Many of these opportunities are thanks to dedicated educators who work to make them engaging, enlightening and memorable. They help us understand the world we live in today and provide tools we can use to shape our tomorrows. Dr. Marti Lindsey is a great example of an educator who is making a difference here in Arizona and across the Southwest region.”Continue reading
Better samples, better science: new study explores integrity of research specimens
Ensuring the proper handling of biological samples used for research is the first step in careful research that meets the necessary high standards of reliability and reproducibility. A new test, which relies on accurate measurement of the relative proportions of two forms of the protein albumin present in blood, was recently described in the journal Molecular and Cellular Proteomics.Continue reading
Monica Kraft, MD of the University of Arizona named Arizona Bioscience Researcher for the Year
CHANDLER, Ariz — (BUSINESS WIRE) — The Arizona Bioindustry Association (AZBio) today announced that Monica Kraft, MD, professor and chair of the Department of Medicine and The Robert and Irene Flinn Endowed Chair of Medicine at the University of Arizona College of Medicine – Tucson, and deputy director of the UA Health Sciences Asthma and Airway Disease Research Center, will be honored as the Arizona Bioscience Researcher of the Year for her work on precision medicine therapies to treat severe asthma.
Continue reading
Innovative Data and Analytics Platform to Accelerate Drug Development for Rare Diseases
Launched by C-Path and NORD through an FDA grant, the goal of the new platform is to accelerate the development of cures by addressing the need to better characterize rare diseases.Continue reading
INanoBio to Receive Up to $5.4 Million to Develop an Epigenetic Sequencer for Detecting WMD Exposures
TEMPE, Ariz.–(BUSINESS WIRE)–INanoBio, a startup developing early stage disease diagnostics by combining semiconductor nanotechnology with biotechnology and machine learning, to receive up to $5.4 Million over four years as part of the Defense Advanced Research Projects Agency (DARPA) contract worth up to $27.8 Million awarded to consortium led by the Icahn School of Medicine at Mount Sinai New York.Continue reading
NeuroEM Study Reports Alzheimer’s Memory Loss Reversed by New Head Device Using Electromagnetic Waves
- Just released new results in the Journal of Alzheimer’s Disease indicate that in-home treatment with a bioengineered head device emitting electromagnetic waves reversed memory impairment of Alzheimer’s patients (AD)
- After two months of Transcranial Electromagnetic Treatment (TEMT), average memory decline in nearly all patients was reversed back to their better cognitive levels of one year earlier.
- Findings point to a potential breakthrough in AD treatment, with TEMT apparently effecting the Alzheimer’s disease process itself within brain cells